Why would the FDA make such an outrageous decision to enter into an unprecedented agreement to monitor post-marketing drug surveillance with a private company run by ex-pharmaceutical executives? The FDA would be better off looking at its FAERS data. If they did, they would see drug signals that they have ignored, especially for FQ's.
It is my regret to inform those reading, as a founding member and first director of the Quinolone Vigilance Foundation (QVF), I am forced to withdraw my support of the QVF and have no confidence in its current leadership.
This is the final part in a two part hard hitting OP-ED series why WEGO Health is NOT consistent with Fluoroquinolone Community goals.
Do we welcome an organization into our midst that; employs former pharmaceutical execs? Sponsors events attended by pharmaceutical companies? Most of which have connections to Fluoroquinolones?